Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 98,875 shares at $176.20 ($16.8M) on 2018-06-19, disclosed to the SEC on 2018-06-21.
Open-market sale of $16.8M LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,000 | $0 | 0.0% |
| 2 | $176.20 | 2,336 | $412K | 2.5% |
| 3 | $176.20 | 2,336 | $412K | 2.5% |
| 4 | $177.06 | 3,427 | $607K | 3.6% |
| 5 | $177.06 | 3,427 | $607K | 3.6% |
| 6 | $177.44 | 8,232 |
| $1.5M |
| 8.7% |
| 7 | $178.12 | 1,737 | $309K | 1.8% |
| 8 | $178.12 | 1,737 | $309K | 1.8% |
| 9 | $178.30 | 8,763 | $1.6M | 9.3% |
| 10 | $179.83 | 3,902 | $702K | 4.2% |
| 11 | $179.83 | 3,902 | $702K | 4.2% |
| 12 | $180.34 | 103 | $19K | 0.1% |
| 13 | $180.34 | 103 | $19K | 0.1% |
| 14 | $178.81 | 2,700 | $483K | 2.9% |
| 15 | $178.94 | 11,336 | $2.0M | 12.1% |
| 16 | $178.94 | 11,336 | $2.0M | 12.1% |
| 17 | $179.37 | 4,370 | $784K | 4.7% |
| 18 | $179.37 | 4,370 | $784K | 4.7% |
| 19 | $179.77 | 9,664 | $1.7M | 10.4% |
| 20 | $179.77 | 9,664 | $1.7M | 10.4% |
| 21 | $180.90 | 430 | $78K | 0.5% |
| Total | $169.70 avg | 98,875 | $16.8M | 100% |
| Filing → |
| LOXO | SELL | 2018-11-28 | $2.9M | — | Filing → |
| LOXO | SELL | 2018-10-05 | $5.4M | — | Filing → |
| LOXO | SELL | 2018-09-14 | $5.0M | — | Filing → |